Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
-92,823
% of shares
-3.83%
Amount (USD)
$1,493,427
Insider confidence score
36.3 out of 100
Positive
Negative
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+14,722.0
Price per Share
$6.55
Amount (USD)
$96,429.10
Acquired/Disposed
Acquired
Shares Owned Before
588,249.0
Shares Owned After
602,971.0
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+11,881.0
Price per Share
$12.14
Amount (USD)
$144,235.34
Acquired/Disposed
Acquired
Shares Owned Before
602,971.0
Shares Owned After
614,852.0
Security
Common Stock
Action
Sell
Date
2026-03-03
Code
S
Net shares
-24,423.0
Price per Share
$15.49
Amount (USD)
$378,312.27
Acquired/Disposed
Disposed
Shares Owned Before
614,852.0
Shares Owned After
590,429.0
Security
Common Stock
Action
Sell
Date
2026-03-03
Code
S
Net shares
-6,518.0
Price per Share
$16.33
Amount (USD)
$106,438.94
Acquired/Disposed
Disposed
Shares Owned Before
590,429.0
Shares Owned After
583,911.0
Security
Common Stock
Action
Exercise
Date
2026-03-04
Code
M
Net shares
+14,722.0
Price per Share
$6.55
Amount (USD)
$96,429.10
Acquired/Disposed
Acquired
Shares Owned Before
583,911.0
Shares Owned After
598,633.0
Security
Common Stock
Action
Exercise
Date
2026-03-04
Code
M
Net shares
+11,881.0
Price per Share
$12.14
Amount (USD)
$144,235.34
Acquired/Disposed
Acquired
Shares Owned Before
598,633.0
Shares Owned After
610,514.0
Security
Common Stock
Action
Sell
Date
2026-03-04
Code
S
Net shares
-30,941.0
Price per Share
$16.60
Amount (USD)
$513,620.60
Acquired/Disposed
Disposed
Shares Owned Before
610,514.0
Shares Owned After
579,573.0
Security
Common Stock
Action
Exercise
Date
2026-03-05
Code
M
Net shares
+14,722.0
Price per Share
$6.55
Amount (USD)
$96,429.10
Acquired/Disposed
Acquired
Shares Owned Before
579,573.0
Shares Owned After
594,295.0
Security
Common Stock
Action
Exercise
Date
2026-03-05
Code
M
Net shares
+11,881.0
Price per Share
$12.14
Amount (USD)
$144,235.34
Acquired/Disposed
Acquired
Shares Owned Before
594,295.0
Shares Owned After
606,176.0
Security
Common Stock
Action
Sell
Date
2026-03-05
Code
S
Net shares
-30,941.0
Price per Share
$16.00
Amount (USD)
$495,056.00
Acquired/Disposed
Disposed
Shares Owned Before
606,176.0
Shares Owned After
575,235.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-14,722.0
Acquired/Disposed
Disposed
Shares Owned Before
195,325.0
Shares Owned After
180,603.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-11,881.0
Acquired/Disposed
Disposed
Shares Owned Before
463,344.0
Shares Owned After
451,463.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-04
Code
M
Net shares
-14,722.0
Acquired/Disposed
Disposed
Shares Owned Before
180,603.0
Shares Owned After
165,881.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-04
Code
M
Net shares
-11,881.0
Acquired/Disposed
Disposed
Shares Owned Before
451,463.0
Shares Owned After
439,582.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-05
Code
M
Net shares
-14,722.0
Acquired/Disposed
Disposed
Shares Owned Before
165,881.0
Shares Owned After
151,159.0
Security
Stock Option (right to buy)
Action
Exercise
Date
2026-03-05
Code
M
Net shares
-11,881.0
Acquired/Disposed
Disposed
Shares Owned Before
439,582.0
Shares Owned After
427,701.0
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
2. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.11 to $16.10, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
3. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.56, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
4. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.35 to $16.94, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
5. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.74 to $16.30, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
6. The option is fully vested and exercisable.
7. The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
ℹ️ Filed under Rule 10b5-1 trading plan
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.